Frequency of Abnormal Findings Detected by Comprehensive Clinical Evaluation at 1 Year after Allogeneic Hematopoietic Cell Transplantation

Biology of Blood and Marrow Transplantation

Volumn 15, Issue 4, 2009, Pages 416-420

  Lee, Stephanie J ^a   Seaborn, Travis ^a   Mao, Frances J ^a   Massey, Susan C ^a   Luu, Ngoc Q ^a   Schubert, Mary A ^b   Chien, Jason W ^a   Carpenter, Paul A ^a   Moravec, Carina ^b   Martin, Paul J ^a   Flowers, Mary E D ^a  

^a Fred Hutchinson Cancer Research Center   (United States)

^b Long Term Follow Up Unit   (United States)

Author keywords

Allogeneic hematopoietic cell transplantation; Chronic graft versus host disease; Hypothyroidism; Immunity; Late effects; Osteoporosis; Recurrent malignancy

Indexed keywords

ANTIDEPRESSANT AGENT; ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; ANTIINFECTIVE AGENT; ANTILIPEMIC AGENT; BISPHOSPHONIC ACID DERIVATIVE; CALCINEURIN INHIBITOR; CORTICOSTEROID; GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; CANCER CENTER; CANCER RECURRENCE; CANCER SURVIVOR; CHRONIC GRAFT VERSUS HOST DISEASE; CLINICAL EVALUATION; CONSENSUS; CONTROLLED STUDY; EARLY DIAGNOSIS; EARLY INTERVENTION; FEMALE; FOLLOW UP; HUMAN; HYPERLIPIDEMIA; LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MORBIDITY; MORTALITY; OSTEOPENIA; OSTEOPOROSIS; PRACTICE GUIDELINE; SCREENING;

ADULT; FASTING; FEMALE; FOLLOW-UP STUDIES; GRAFT VS HOST DISEASE; GUIDELINES AS TOPIC; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; HYPERLIPIDEMIAS; LUNG DISEASES; MALE; OSTEOPOROSIS; PREVALENCE; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 61849121316     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2008.12.502     Document Type: Article

References (20)

1. Stern J.M., Sullivan K.M., Ott S.M., et al. Bone density loss after allogeneic hematopoietic stem cell transplantation: a prospective study. Biol Blood Marrow Transplant 7 (2001) 257-264
2. Socie G., Salooja N., Cohen A., et al. Nonmalignant late effects after allogeneic stem cell transplantation. Blood 101 (2003) 3373-3385
3. Baker K.S., Gurney J.G., Ness K.K., et al. Late effects in survivors of chronic myeloid leukemia treated with hematopoietic cell transplantation: results from the Bone Marrow Transplant Survivor Study. Blood 104 (2004) 1898-1906
4. Savani B.N., Montero A., Srinivasan R., et al. Chronic GVHD and pretransplantation abnormalities in pulmonary function are the main determinants predicting worsening pulmonary function in long-term survivors after stem cell transplantation. Biol Blood Marrow Transplant 12 (2006) 1261-1269
5. Fraser C.J., Bhatia S., Ness K., et al. Impact of chronic graft-versus-host disease on the health status of hematopoietic cell transplantation survivors: a report from the Bone Marrow Transplant Survivor Study. Blood 108 (2006) 2867-2873
6. Baker K.S., Ness K.K., Steinberger J., et al. Diabetes, hypertension, and cardiovascular events in survivors of hematopoietic cell transplantation: a report from the Bone Marrow Transplantation Survivor Study. Blood 109 (2007) 1765-1772
7. Savani B.N., Donohue T., Kozanas E., et al. Increased risk of bone loss without fracture risk in long-term survivors after allogeneic stem cell transplantation. Biol Blood Marrow Transplant 13 (2007) 517-520
8. Tichelli A., Bucher C., Rovo A., et al. Premature cardiovascular disease after allogeneic hematopoietic stem-cell transplantation. Blood 110 (2007) 3463-3471
9. Carpenter P.A., Hoffmeister P., Chesnut III C.H., et al. Bisphosphonate therapy for reduced bone mineral density in children with chronic graft-versus-host disease. Biol Blood Marrow Transplant 13 (2007) 683-690
10. Leung W., Ahn H., Rose S.R., et al. A prospective cohort study of late sequelae of pediatric allogeneic hematopoietic stem cell transplantation. Medicine (Baltimore) 86 (2007) 215-224
11. Antin J.H. Clinical practice: long-term care after hematopoietic cell transplantation in adults. N Engl J Med 347 (2002) 36-42
12. Landier W., Bhatia S., Eshelman D.A., et al. Development of risk-based guidelines for pediatric cancer survivors: the Children's Oncology Group Long-Term Follow-Up Guidelines from the Children's Oncology Group Late Effects Committee and Nursing Discipline. J Clin Oncol 22 (2004) 4979-4990
13. Flowers M.E.D., and Deeg H.J. Delayed complications after hematopoietic cell transplantation. In: Blume K.G., Forman S.J., and Appelbaum F.R. (Eds). Thomas' Hematopoietic Cell Transplantation. Third edition (2004), Blackwell, Oxford, UK 944-961
14. Rizzo J.D., Wingard J.R., Tichelli A., et al. Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation: joint recommendations of the European Group for Blood and Marrow Transplantation, the Center for International Blood and Marrow Transplant Research, and the American Society of Blood and Marrow Transplantation. Biol Blood Marrow Transplant 12 (2006) 138-151
15. Filipovich A.H., Weisdorf D., Pavletic S., et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease, I: diagnosis and staging working group report. Biol Blood Marrow Transplant 11 (2005) 945-956
16. Pavletic S.Z., Martin P., Lee S.J., et al. Measuring therapeutic response in chronic graft-versus-host disease. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease IV: Response Criteria Working Group report. Biol Blood Marrow Transplant 12 (2006) 252-266
17. Majhail N.S., Flowers M.E., Ness K.K., et al. High prevalence of metabolic syndrome after allogeneic hematopoietic cell transplantation. Bone Marrow Transplant (2008)
18. Savani B.N., Stratton P., Shenoy A., et al. Increased risk of cervical dysplasia in long-term survivors of allogeneic stem cell transplantation: implications for screening and HPV vaccination. Biol Blood Marrow Transplant 14 (2008) 1072-1075
19. Socie G., Stone J.V., Wingard J.R., et al. Long-term survival and late deaths after allogeneic bone marrow transplantation. Late Effects Working Committee of the International Bone Marrow Transplant Registry. N Engl J Med 341 (1999) 14-21
20. Bhatia S., Francisco L., Carter A., et al. Late mortality after allogeneic hematopoietic cell transplantation and functional status of long-term survivors: report from the Bone Marrow Transplant Survivor Study. Blood 110 (2007) 3784-3792